Rui and coworkers identified five significantly upregulated exosome-derived piRNAs, piR-1029, piR-15254, piR-35395, piR-32132, and piR-43597, which could be used as biomarkers for HCC diagnosis [387]. The gene discussed is PIR; the disease is hepatocellular carcinoma.